COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome

1

A cohort study evaluated COVID-19 outcomes in 254 allogeneic stem cell transplant recipients at San Raffaele Scientific Institute in Italy.
2

Among the evaluated patients, six tested positive for COVID-19, with symptoms ranging from mild to moderate respiratory issues.
3

No patients developed severe complications like ARDS or required intensive care, and all six patients eventually recovered.
4

Patients received various treatments, including antiviral therapy and hydroxychloroquine, based on institutional guidelines.
5

The study highlights the favorable outcomes of COVID-19 in stem cell transplant recipients compared to general population trends.

Bone Marrow Transplantation

by Maria Teresa Lupo-Stanghellini, Elisabetta Xue, Sara Mastaglio, Chiara Oltolini, Piera Angelillo, Carlo Messina, Simona Piemontese, Stefania Girlanda, Francesca Farina, Lorenzo Lazzari, Maria Pia Cicalese, Federico Erbella, Raffaella Greco, Massimo Locatelli, Raffaella Milani, Jacopo Peccatori, Consuelo Corti, Sarah Marktel, Andrea Assanelli, Fabio Ciceri
June 30, 2021

1